Literature DB >> 17079667

Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.

Fabrizio G Mastronardi1, D Denise Wood, Jiang Mei, Reinout Raijmakers, Vivian Tseveleki, Hans-Michael Dosch, Lesley Probert, Patrizia Casaccia-Bonnefil, Mario A Moscarello.   

Abstract

Modification of arginine residues by citrullination is catalyzed by peptidylarginine deiminases (PADs), of which five are known, generating irreversible protein structural modifications. We have shown previously that enhanced citrullination of myelin basic protein contributed to destabilization of the myelin membrane in the CNS of multiple sclerosis (MS) patients. We now report increased citrullination of nucleosomal histones by PAD4 in normal-appearing white matter (NAWM) of MS patients and in animal models of demyelination. Histone citrullination was attributable to increased levels and activity of nuclear PAD4. PAD4 translocation into the nucleus was attributable to elevated tumor necrosis factor-alpha (TNF-alpha) protein. The elevated TNF-alpha in MS NAWM was not associated with CD3+ or CD8+ lymphocytes, nor was it associated with CD68+ microglia/macrophages. GFAP, a measure of astrocytosis, was the only cytological marker that was consistently elevated in the MS NAWM, suggesting that TNF-alpha may have been derived from astrocytes. In cell cultures of mouse and human oligodendroglial cell lines, PAD4 was predominantly cytosolic but TNF-alpha treatment induced its nuclear translocation. To address the involvement of TNF-alpha in targeting PAD4 to the nucleus, we found that transgenic mice overexpressing TNF-alpha also had increased levels of citrullinated histones and elevated nuclear PAD4 before demyelination. In conclusion, high citrullination of histones consequent to PAD4 nuclear translocation is part of the process that leads to irreversible changes in oligodendrocytes and may contribute to apoptosis of oligodendrocytes in MS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079667      PMCID: PMC6674531          DOI: 10.1523/JNEUROSCI.3349-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  82 in total

1.  Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.

Authors:  Yudong Liu; Yaíma L Lightfoot; Nickie Seto; Carmelo Carmona-Rivera; Erica Moore; Rishi Goel; Liam O'Neil; Pragnesh Mistry; Victoria Hoffmann; Santanu Mondal; Padmavathy Nandha Premnath; Katherine Gribbons; Stefania Dell'Orso; Kan Jiang; Paul R Thompson; Hong-Wei Sun; Scott A Coonrod; Mariana J Kaplan
Journal:  JCI Insight       Date:  2018-12-06

2.  Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes.

Authors:  Vivian Tseveleki; Renee Rubio; Sotiris-Spyros Vamvakas; Joseph White; Era Taoufik; Edwige Petit; John Quackenbush; Lesley Probert
Journal:  Genomics       Date:  2010-05-07       Impact factor: 5.736

3.  Expression of peptidylarginine deiminase 4 in an alkali injury model of retinal gliosis.

Authors:  John W Wizeman; Royce Mohan
Journal:  Biochem Biophys Res Commun       Date:  2017-04-08       Impact factor: 3.575

Review 4.  Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease.

Authors:  Siming Shen; Patrizia Casaccia-Bonnefil
Journal:  J Mol Neurosci       Date:  2008-05       Impact factor: 3.444

5.  Alterations of histone modifications by cobalt compounds.

Authors:  Qin Li; Qingdong Ke; Max Costa
Journal:  Carcinogenesis       Date:  2009-04-17       Impact factor: 4.944

Review 6.  Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging.

Authors:  Sjef Copray; Jimmy Long Huynh; Falak Sher; Patrizia Casaccia-Bonnefil; Erik Boddeke
Journal:  Glia       Date:  2009-11-15       Impact factor: 7.452

Review 7.  Epigenetics of multiple sclerosis: an updated review.

Authors:  Cem İsmail Küçükali; Murat Kürtüncü; Arzu Çoban; Merve Çebi; Erdem Tüzün
Journal:  Neuromolecular Med       Date:  2014-03-21       Impact factor: 3.843

Review 8.  Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.

Authors:  Erin E Witalison; Paul R Thompson; Lorne J Hofseth
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

9.  EPIGENETIC MECHANISMS IN MULTIPLE SCLEROSIS.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Rev Esp Escler Mult       Date:  2014-03

10.  Large-scale comparative assessment of computational predictors for lysine post-translational modification sites.

Authors:  Zhen Chen; Xuhan Liu; Fuyi Li; Chen Li; Tatiana Marquez-Lago; André Leier; Tatsuya Akutsu; Geoffrey I Webb; Dakang Xu; Alexander Ian Smith; Lei Li; Kuo-Chen Chou; Jiangning Song
Journal:  Brief Bioinform       Date:  2019-11-27       Impact factor: 11.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.